Patents

US 12741962 B2: 2,3-disubstituted pyrido[3,4-b]pyrazine-containing compounds as kinase inhibitors

Granted
2026-09-22
Filed
2021-06-24 application 18009311
Type
Utility · 1 claim
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention generally relates to 2,3-Disubstituted pyrido[3,4-b]pyrazine-containing compounds as a kinase inhibitor and methods of uses thereof. Pharmaceutical compositions and methods for treating those kinase related diseases are within the scope of this invention.

Source: PTBLXML, file of 2026-09-22 (ipgb20260922.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Purdue Research Foundation 2,151 patentsUS company or organizationWest Lafayette, INPURDUE RESEARCH FOUNDATION Nonprofit EXACT high confidence: identical full name and statePTBLXML, file of 2026-09-22

Inventors

InventorPlacePatentsPerson pageSource
Herman O. SintimWestfield, IN12PTBLXML, file of 2026-09-22
Elizabeth Anne LarocqueLowell, MAPTBLXML, file of 2026-09-22
Delmis E. HernandezLafayette, INPTBLXML, file of 2026-09-22
Neetu DayalAgra, IN4PTBLXML, file of 2026-09-22

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D403/14PTBLXML, file of 2026-09-22
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PTBLXML, file of 2026-09-22

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.